StreetInsider.com News Articles

LataMed AI Corp. to Attend MEDICA 2026 in Germany as Company Advances Innovative Healthcare Technology Strategy

Thu, 28 May 2026 09:30:00 -0400

CARACAS, VENEZUELA - May 28, 2026 (NEWMEDIAWIRE) - LataMed AI Corp. (OTC: LMED) (the Company), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure and healthcare analytics platforms for emerging markets, today announced that Company representatives plan to attend MEDICA 2026 in Dusseldorf, Germany, one of the worlds largest international healthcare and medical technology trade fairs.

Management stated that attendance at MEDICA is intended to support the Companys ongoing evaluation of healthcare technologies, strategic industry relationships, vendor solutions, digital infrastructure initiatives, and broader commercialization opportunities associated with the Companys developing healthcare technology ecosystem.

The Company plans

LataMed AI Corp. to Attend MEDICA 2026 in Germany as Company Advances Innovative Healthcare Technology Strategy

Thu, 28 May 2026 09:30:00 -0400

The Company plans

LataMed AI Corp. to Attend MEDICA 2026 in Germany as Company Advances Innovative Healthcare Technology Strategy

Thu, 28 May 2026 09:30:00 -0400

The Company plans

LataMed AI Corp. to Attend MEDICA 2026 in Germany as Company Advances Innovative Healthcare Technology Strategy

Thu, 28 May 2026 09:30:00 -0400

The Company plans

LataMed AI Corp. to Attend MEDICA 2026 in Germany as Company Advances Innovative Healthcare Technology Strategy

Thu, 28 May 2026 09:30:00 -0400

The Company plans

LataMed AI Announces AI-Powered Pharmacy Fulfillment Initiative With Venezuelan Pharmacy Operators

Tue, 26 May 2026 09:00:00 -0400

CARACAS, VENEZUELA - May 26, 2026 (NEWMEDIAWIRE) - LataMed AI Corp. (OTC: LMED) (the Company), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure and healthcare analytics platforms for emerging markets, today announced that it has reached commercial terms with two leading pharmacy retail operators in Caracas, Venezuela, to support the planned deployment of the Companys AI-powered prescription processing and pharmaceutical fulfillment platform.

The planned initiative is expected to support the Companys broader Latin American commercialization strategy and establish an initial operational framework for its expanding AI-driven healthcare logistics ecosystem.

The Company stated that Venezuela is

LataMed AI Announces AI-Powered Pharmacy Fulfillment Initiative With Venezuelan Pharmacy Operators

Tue, 26 May 2026 09:00:00 -0400

The Company stated that Venezuela is

LataMed AI Announces AI-Powered Pharmacy Fulfillment Initiative With Venezuelan Pharmacy Operators

Tue, 26 May 2026 09:00:00 -0400

The Company stated that Venezuela is

LataMed AI Highlights Planned Emergency Medical Response Feature Within Telehealth Platform Infrastructure

Tue, 19 May 2026 09:30:00 -0400

CARACAS, VENEZUELA - May 19, 2026 (NEWMEDIAWIRE) - LataMed AI Corp. (OTC: LMED) (the Company), a digital health and artificial intelligence technology company focused on telehealth infrastructure and healthcare analytics platforms for emerging markets, today highlighted a planned emergency medical response feature being integrated into the Companys broader healthcare coordination and telehealth platform infrastructure.

According to the Company, the planned feature is intended to leverage geolocation technology designed to help users rapidly connect with nearby ambulance providers, emergency medical services, clinics, hospitals, and healthcare personnel during emergency situations.

The Company stated that the platform is being designed to streamline emergency

LataMed AI Highlights Planned Emergency Medical Response Feature Within Telehealth Platform Infrastructure

Tue, 19 May 2026 09:30:00 -0400

The Company stated that the platform is being designed to streamline emergency

LataMed AI Highlights Planned Emergency Medical Response Feature Within Telehealth Platform Infrastructure

Tue, 19 May 2026 09:30:00 -0400

The Company stated that the platform is being designed to streamline emergency

LataMed AI gets FINRA approval for name change from Catalyst Crew

Mon, 11 May 2026 08:33:03 -0400

LataMed AI Corp. (OTC: LMED) received confirmation from FINRA for its corporate name and trading symbol change from Catalyst Crew Technologies Corp. (OTC: CCTC), according to a company statement.

Trading under the new LMED ticker symbol will begin at market open on May 11, 2026, following FINRA's Daily List notification published on May 8, 2026.

The digital health and artificial intelligence technology company focuses on telehealth infrastructure and healthcare analytics platforms for emerging markets. The corporate action does not involve any stock split, recapitalization, or changes to the company's authorized share structure.

Existing shareholders are not required to take any action in connection

LataMed AI gets FINRA approval for name change from Catalyst Crew

Mon, 11 May 2026 08:33:03 -0400

LataMed AI Corp. (OTC: LMED) received confirmation from FINRA for its corporate name and trading symbol change from Catalyst Crew Technologies Corp. (OTC: CCTC), according to a company statement.

Trading under the new LMED ticker symbol will begin at market open on May 11, 2026, following FINRA's Daily List notification published on May 8, 2026.

Existing shareholders are not required to take any action in connection

LataMed AI Corp. Announces Expected Effectiveness of Name and Symbol Change to LMED

Fri, 08 May 2026 08:59:00 -0400

CARACAS, VENEZUELA - May 8, 2026 (NEWMEDIAWIRE) - LataMed AI Corp. (OTC: CCTC), formerly Catalyst Crew Technologies Corp., today announced that the Financial Industry Regulatory Authority (FINRA) has processed the Companys requested corporate action relating to its previously disclosed corporate name and trading symbol change. The Company is expected to begin trading under the name LataMed AI Corp. and symbol LMED effective May 11, 2026.

According to FINRAs notification, the Companys name change to LataMed AI Corp. and trading symbol change to LMED are expected to become effective in the marketplace at the open of trading on May 11, 2026.

LataMed AI Corp. Announces Expected Effectiveness of Name and Symbol Change to LMED

Fri, 08 May 2026 08:59:00 -0400

LataMed AI Corp. Announces Expected Effectiveness of Name and Symbol Change to LMED

Fri, 08 May 2026 08:59:00 -0400

LataMed AI Corp. Announces Expected Effectiveness of Name and Symbol Change to LMED

Fri, 08 May 2026 08:59:00 -0400

LataMed AI completes name change, plans share cancellation

Thu, 07 May 2026 09:00:26 -0400

LataMed AI Corp. (OTC: CCTC), formerly Catalyst Crew Technologies Corp., completed a corporate name change through filings with the Nevada Secretary of State. The company expects the FINRA corporate action process to become effective in the near term.

The digital health and artificial intelligence technology company announced completion of internal corporate approvals for a capital restructuring initiative. Chief Executive Officer Dr. Kevin Rodan Levy will voluntarily surrender 20,000,000 shares of restricted common stock for cancellation.

The restructuring would reduce the company's issued and outstanding common stock by approximately 35.6%. As part of the initiative, the company approved establishment of a new class

LataMed AI completes name change, plans share cancellation

Thu, 07 May 2026 09:00:26 -0400

The restructuring would reduce the company's issued and outstanding common stock by approximately 35.6%. As part of the initiative, the company approved establishment of a new class

Catalyst Crew Technologies Provides Update on Share Cancellation Initiative and Corporate Name Change

Thu, 07 May 2026 09:00:00 -0400

CARACAS, VENEZUELA - May 7, 2026 (NEWMEDIAWIRE) - Catalyst Crew Technologies Corp., now known as LataMed AI Corp., (OTC: CCTC) (the Company), a digital health and artificial intelligence technology company focused on telehealth infrastructure and healthcare analytics platforms for emerging markets, today provided an update regarding its previously announced strategic capital restructuring initiative and pending corporate name change process.

As previously disclosed, the Company has completed a corporate name change from Catalyst Crew Technologies Corp. to LataMed AI Corp. through filings with the Nevada Secretary of State. The Company currently expects the related FINRA corporate action process to become effective

Catalyst Crew Technologies Provides Update on Share Cancellation Initiative and Corporate Name Change

Thu, 07 May 2026 09:00:00 -0400

Catalyst Crew Technologies Establishes LataMed AI VE, C.A. to Support Venezuelan Telehealth Operations

Mon, 04 May 2026 21:58:00 -0400

CARACAS, VENEZUELA - May 4, 2026 (NEWMEDIAWIRE) - Catalyst Crew Technologies Corp. (OTC: CCTC) (the Company), a digital health and artificial intelligence technology company developing telehealth infrastructure and healthcare analytics platforms for emerging markets, today announced the establishment of LataMed AI VE, C.A., a new Venezuelan operating subsidiary intended to support the Companys telehealth regulatory, commercialization, and healthcare deployment initiatives within Venezuela.

The Company expects that LataMed AI VE, C.A. will serve as a principal localized operating entity supporting the phased deployment of the Companys telehealth platform, broader healthcare delivery infrastructure, and regulatory progression efforts within Venezuela. Management currently anticipates

Catalyst Crew Technologies Establishes LataMed AI VE, C.A. to Support Venezuelan Telehealth Operations

Mon, 04 May 2026 21:58:00 -0400

Catalyst Crew Technologies to Attend HLTH Europe 2026

Mon, 27 Apr 2026 09:30:00 -0400

CARACAS, VENEZUELA - April 27, 2026 (NEWMEDIAWIRE) - Catalyst Crew Technologies Corp. (OTC: CCTC) (the Company), a digital health and artificial intelligence technology company developing telehealth infrastructure and healthcare analytics platforms for emerging markets, today announced that Dr. Kevin Rodan Levy, Chief Executive Officer of the Company, plans to attend HLTH Europe 2026, an international healthcare conference focused on digital health, healthcare innovation, and emerging technologies. HLTH Europe 2026 is scheduled to take place in Amsterdam from June 15-18.

Dr. Levys attendance is intended to support the Companys broader strategic initiatives, including engagement with healthcare industry participants, evaluation of emerging

Catalyst Crew Technologies to Attend HLTH Europe 2026

Mon, 27 Apr 2026 09:30:00 -0400

Dr. Levys attendance is intended to support the Companys broader strategic initiatives, including engagement with healthcare industry participants, evaluation of emerging